Acidosis, Lactic
7
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV
Preoperative Parenteral Thiamine Supplementation in Patients Undergoing Heart Surgery
Whole Body Periodic Acceleration on Blood Lactate and Recovery
Prevention of Dichloroacetate Toxicity
Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients
Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients
D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)